ID   SM-AP2
AC   CVCL_D118
DR   Wikidata; Q54954887
RX   PubMed=19622142;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=19622142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=19622142).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D117 ! SM-AP1
OI   CVCL_D119 ! SM-AP3
OI   CVCL_D120 ! SM-AP4
OI   CVCL_D121 ! SM-AP5
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=19622142; DOI=10.1186/1471-2407-9-247; PMCID=PMC2722671;
RA   Maruyama S., Cheng J., Shingaki S., Tamura T., Asakawa S.,
RA   Minoshima S., Shimizu Y., Shimizu N., Saku T.;
RT   "Establishment and characterization of pleomorphic adenoma cell
RT   systems: an in-vitro demonstration of carcinomas arising secondarily
RT   from adenomas in the salivary gland.";
RL   BMC Cancer 9:247.1-247.17(2009).
//